We are happy to announce our Wholesale Distributor Authorisation (WDA) has been approved. It’s a significant milestone for the company and presents us with fresh chances to increase the number of products we offer. There are some great ideas and projects brewing in early states… Read More »Wholesale Distributor Authorisation
Team Neobiomics exhibited at the 55th Annual Meeting of ESPGHAN 2023 in Vienna, Austria. Neobiomics was represented by Vera Westin, Customer Support Manager and Sneha Challapilli, Project Manager. As this was an international conference, it was a pleasure meeting delegates and representatives from different parts… Read More »Team Neobiomics at ESPGHAN 2023
Neobiomics held its Annual General Meeting for the fiscal year 2022. We were grateful for the support of our investors, board members, and coworkers. In addition to formal presentations about the previous year’s operations, our goal was for us to interact and stay up to… Read More »Annual General Meeting, 2023
Neobiomics attended the Annual Preterm Symposium in Cologne, Germany & the British Association of Perinatal Medicine’s Spring Conference in Edinburgh We participated in the Annual Preterm Symposium in Cologne, Germany, on April 22, 2023, which was very well organized by Dr Angela Kribs. Frank Alkenbrecher represented… Read More »Neobiomics: April 2023
Team Neobiomics was happy to participate in the DRIVE Investor Day 2023, organized by Karolinska Instititet Innovation AB. With several companies participating in this event, we were represented by Stefan Johansson, CEO. This allowed us to present Neobiomics, our current and future goals. We saw… Read More »DRIVE Investor Day 2023